Contributors
LWD, RA, VF
AM, RA, HMEH, LWD, MF, MAH, FS, and BG contributed to the conception and design of the study. AM, RA, JB, MK, LS, SS, and VF were involved in data collection. Qvigilance, the pharmacovigilance CRO, was responsible for maintaining the safety database and partly carried out the safety analysis. AM, MF and BG analysed and interpreted safety data. RA and FS analysed and interpreted immunogenicity data. AM, RA, JB, MF, and VF accessed and verified the underlying data. AM and RA wrote the manuscript, and all authors contributed to its revision. All authors read and approved the final version of the manuscript.